Lv5
1390 积分 2025-02-25 加入
抗肿瘤药物引起手足综合征的机制及防治措施
2个月前
已完结
Forward and reverse cardio-oncology
2个月前
已完结
Pharmacokinetic exposure and treatment outcomes of lenvatinib in patients with renal cell carcinoma and differentiated thyroid carcinoma
3个月前
已完结
A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
3个月前
已完结
The benefit of conversion therapy for patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab using newly established oncological resectability criteria in Japan
5个月前
已完结
Vulnerable or High-Risk Plaque
9个月前
已完结
皖公网安备34019202002308
